Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 12

1.

Saudi Oncology Society clinical management guidelines for prostate cancer.

Abusamra AJ, Bazarbashi S, Bahader Y, Kushi H, Rabah D, Al Bogami N, Al Ghamdi K, Al Ghamdi A, Balaraj K, Seyam R, Al Otaibi M, Al Saeed E.

Urol Ann. 2011 Mar;3 Suppl:S10-6. doi: 10.4103/0974-7796.78550. Erratum in: Urol Ann. 2011 May;3(2):61. Rabbah, Dany [corrected to Rabah, Danny].

2.

Saudi Oncology Society clinical management guidelines for testicular germ cell tumors.

Al Otaibi M, El-Naghi M, Balaraj K, Bazarbashi S, Rabah D, Al Othman K, Al Saeed E, Al Ghamdi A, Aljubran A, Murshid E, Al Oraifi I, Al Kushi H.

Urol Ann. 2011 Mar;3 Suppl:S17-20. doi: 10.4103/0974-7796.78551. Erratum in: Urol Ann. 2011 May-Aug; 3(2):61. Rabbah, Dany [corrected to Rabah, Danny].

3.

Saudi Oncology Society clinical management guideline series. Colorectal cancer 2014.

Bazarbashi SN, Alzahrani AM, Rahal MM, Al-Shehri AS, Aljubran AH, Alsanea NA, Al-Obeed OA, Kandil MS, Zekri JE, Al Olayan AA, Alsharm AA, Balaraj KS, Fagih MA; Saudi Oncology Society.

Saudi Med J. 2014 Dec;35(12):1538-44. No abstract available.

4.

Saudi Oncology Society clinical management guideline series. Anal canal cancer 2014.

Bazarbashi SN, Alzahrani AM, Rahal MM, Al-Shehri AS, Aljubran AH, Alsanea NA, Al-Obeed OA, Kandil MS, Zekri JE, Al Olayan AA, Alsharm AA, Balaraj KS; Saudi Oncology Society.

Saudi Med J. 2014 Dec;35(12):1527-8. No abstract available.

5.

Anal canal carcinoma treatment results: the experience of a single institution.

El-Haddad M, Ahmed RS, Al-Suhaibany A, Al-Hazza M, Al-Sanae N, Al-Jabbar AA, Hamoud S, Ashaary L, Bazerbashy S, Balaraj K.

Ann Saudi Med. 2011 Mar-Apr;31(2):158-62. doi: 10.4103/0256-4947.77488.

6.

Pre-operative chemoradiotherapy using capecitabine and cetuximab followed by definitive surgery in patients with operable rectal cancer.

Bazarbashi S, Omar A, Aljubran A, Alzahrani A, Alsanea N, Abduljabbar A, Alhomoud S, Ashari L, Balaraj K, Soudy H, Neimatallah M, Fagih M.

Hematol Oncol Stem Cell Ther. 2016 Dec;9(4):147-153. doi: 10.1016/j.hemonc.2016.08.004. Epub 2016 Sep 2.

7.

RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.

Schefter T, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W Jr, Sause W, Gaffney D; Radiation Therapy Oncology Group (RTOG).

Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):101-5. doi: 10.1016/j.ijrobp.2013.10.022.

PMID:
24331655
8.

A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417.

Schefter TE, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W Jr, Gaffney DK.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1179-84. doi: 10.1016/j.ijrobp.2011.10.060. Epub 2012 Feb 16.

PMID:
22342094
9.

Saudi Oncology Society clinical management guidelines for urinary bladder cancer.

Al Othman K, Bazarbashi S, Balaraj K, Al Otaibi M, Kamal B, Al Oraifi I, Al Saeed E, Al Gamdi K, Jubran A, Salah A, Al Shareef J, Zekri J.

Urol Ann. 2011 Mar;3 Suppl:S6-9. doi: 10.4103/0974-7796.78549.

10.

Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia.

Alsbeih G, Ahmed R, Al-Harbi N, Venturina LA, Tulbah A, Balaraj K.

Gynecol Oncol. 2011 Jun 1;121(3):522-6. doi: 10.1016/j.ygyno.2011.01.033. Epub 2011 Feb 24.

PMID:
21353296
11.

Evaluating contemporary radiotherapy approaches in the primary treatment of cervical cancer.

Samant R, Kobeleva S, E C, Balaraj K, Le T, Fung-Kee-Fung M.

Int J Gynecol Cancer. 2010 Aug;20(6):1087-91. doi: 10.1111/IGC.0b013e3181e0ef81.

PMID:
20683423
12.

Laparoscopic ovarian transposition before pelvic irradiation: a Saudi tertiary center experience.

Al-Badawi IA, Al-Aker M, AlSubhi J, Salem H, Abduljabbar A, Balaraj K, Munkarah A.

Int J Gynecol Cancer. 2010 Aug;20(6):1082-6. doi: 10.1111/IGC.0b013e3181e2ace5.

PMID:
20683422

Supplemental Content

Support Center